Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

被引:29
|
作者
Brown, Justin C. [1 ]
Rhim, Andrew D. [2 ]
Manning, Sara L. [3 ]
Brennan, Luke [3 ]
Mansour, Alexandra I. [3 ]
Rustgi, Anil K. [4 ]
Damjanov, Nevena [4 ]
Troxel, Andrea B. [5 ]
Rickels, Michael R. [4 ]
Ky, Bonnie [4 ]
Zemel, Babette S. [4 ,6 ]
Courneya, Kerry S. [7 ]
Schmitz, Kathryn H. [8 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] NYU, New York, NY USA
[6] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[7] Univ Alberta, Edmonton, AB, Canada
[8] Penn State Coll Med, Hershey, PA USA
来源
PLOS ONE | 2018年 / 13卷 / 10期
基金
美国国家卫生研究院;
关键词
SURROGATE END-POINTS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GROWTH-FACTOR; SHEAR-STRESS; BLOOD-FLOW; MORTALITY; SURVIVORS; OBESITY;
D O I
10.1371/journal.pone.0204875
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Physical activity is associated with a lower risk of disease recurrence among colon cancer patients. Circulating tumor cells (CTC) are prognostic of disease recurrence among stage I-III colon cancer patients. The pathways through which physical activity may alter disease outcomes are unknown, but may be mediated by changes in CTCs. Methods Participants included 23 stage I-III colon cancer patients randomized into one of three groups: usual-care control, 150 min-wk-1 of aerobic exercise (low-dose), and 300 min-wk-1 of aerobic exercise (high-dose) for six months. CTCs from venous blood were quantified in a blinded fashion using an established microfluidic antibody-mediated capture device. Poisson regression models estimated the logarithmic counts of CTCs. Results At baseline, 78% (18/23) of patients had >= 1 CTC. At baseline, older age (-0.12+/- 0.06; P=0.04), lymphovascular invasion (0.63+/-0.25; P=0.012), moderate/poor histology (1.09 +/-0.34; P=0.001), body mass index (0.07+/-0.02; P=0.001), visceral adipose tissue (0.08 +/-0.04; P=0.036), insulin (0.06+/-0.02; P=0.011), sICAM-1 (0.04+/-0.02; P=0.037), and sVCAM-1 (0.06+/-0.03; P=0.045) were associated with CTCs. Over six months, significant decreases in CTCs were observed in the low-dose (-1.34+/-0.34; P<0.001) and high-dose (-1.18+/-0.40; P=0.004) exercise groups, whereas no significant change was observed in the control group (-0.59+/-0.56; P=0.292). Over six months, reductions in body mass index (-0.07+/-0.02; P=0.007), insulin (-0.08+/-0.03; P=0.014), and sICAM-1 (-0.07+/-0.03; P=0.005) were associated with reductions in CTCs. The main limitations of this proof-of-concept study are the small sample size, heterogenous population, and per-protocol statistical analysis. Conclusion Exercise may reduce CTCs among stage I-III colon cancer patients. Changes in host factors correlated with changes in CTCs. Exercise may have a direct effect on CTCs and indirect effects through alterations in host factors. This hypothesis-generating observation derived from a small pilot study warrants further investigation and replication.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Robotic versus laparoscopic colectomy for stage I-III colon cancer: oncologic and long-term survival outcomes
    Mirkin, Katelin A.
    Kulaylat, Audrey S.
    Hollenbeak, Christopher S.
    Messaris, Evangelos
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (06): : 2894 - 2901
  • [42] Prognostic impact of visceral and subcutaneous fat area in stage I-III colon cancer patients with cachexia: a population-based multicenter study
    Liang, Xian-wen
    Wen, Jing
    Liu, Bing
    Wang, Sheng-zhong
    Wu, Jin-cai
    Pan, Tao
    FRONTIERS IN NUTRITION, 2025, 12
  • [43] Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer
    Weiser, Martin R.
    Hsu, Meier
    Bauer, Philip S.
    Chapman, William C.
    Gonzalez, Ivan A.
    Chatterjee, Deyali
    Lingam, Deepak
    Mutch, Matthew G.
    Keshinro, Ajaratu
    Shia, Jinru
    Vakiani, Efsevia
    Konishi, Tsuyoshi
    Shimada, Yoshifumi
    Stadler, Zsofia
    Segal, Neil H.
    Cercek, Andrea
    Saltz, Leonard
    Yaeger, Rona
    Varghese, Anna
    Widmar, Maria
    Wei, Iris H.
    Pappou, Emmanouil P.
    Smith, J. Joshua
    Nash, Garrett
    Paty, Philip
    Garcia-Aguilar, Julio
    Gonen, Mithat
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (08) : 911 - +
  • [44] A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer
    Zhou, Rui
    Zeng, Dongqiang
    Zhang, Jingwen
    Sun, Huiying
    Wu, Jianhua
    Li, Nailin
    Liang, Li
    Shi, Min
    Bin, Jianping
    Liao, Yulin
    Huang, Na
    Liao, Wangjun
    EBIOMEDICINE, 2019, 42 : 420 - 430
  • [45] Is dietary supplement use longitudinally associated with fatigue in stage I-III colorectal cancer survivors?
    Koole, Janna L.
    Sours, Martijn J. L.
    Breedveld-Peters, Jose J. L.
    van Roekel, Eline H.
    Breukink, Stephanie O.
    Janssen-Heijnen, Maryska L. G.
    Vogelaar, F. Jeroen
    Aquarius, Michel
    Keulen, Eric
    Stoot, Jan
    Weijenberg, Matty P.
    CLINICAL NUTRITION, 2020, 39 (01) : 234 - 241
  • [46] The gut microbiome is associated with disease-free survival in stage I-III colorectal cancer patients
    Byrd, Doratha A.
    Damerell, Victoria
    Gomez Morales, Maria F.
    Hogue, Stephanie R.
    Lin, Tengda
    Ose, Jennifer
    Himbert, Caroline
    Ilozumba, Mmadili N.
    Kahlert, Christoph
    Shibata, David
    Toriola, Adetunji T.
    Li, Christopher I.
    Figueiredo, Jane
    Stephens, W. Zac
    Warby, Christy A.
    Hardikar, Sheetal
    Siegel, Erin M.
    Round, June
    Ulrich, Cornelia M.
    Gigic, Biljana
    INTERNATIONAL JOURNAL OF CANCER, 2025,
  • [47] Integrating the symptom experience and coping in patients with stage I-III breast cancer in China: A qualitative study
    Liang, Minyu
    Xiong, Ying
    Zhu, Siying
    Wang, Yishu
    Knobf, M. Tish
    Ye, Zengjie
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2024, 73
  • [48] Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I-III colorectal cancer
    Xie, Hailun
    Wei, Lishuang
    Liu, Mingxiang
    Liang, Yanren
    Yuan, Guanghui
    Gao, Shunhui
    Wang, Qiwen
    Lin, Xin
    Tang, Shuangyi
    Gan, Jialiang
    BMC CANCER, 2022, 22 (01)
  • [49] Incidence and Survival Among Young Women With Stage I-III Breast Cancer: SEER 2000-2015
    Thomas, Alexandra
    Rhoads, Anthony
    Pinkerton, Elizabeth
    Schroeder, Mary C.
    Conway, Kristin M.
    Hundley, William G.
    McNally, Lacey R.
    Oleson, Jacob
    Lynch, Charles F.
    Romitti, Paul A.
    JNCI CANCER SPECTRUM, 2019, 3 (03)
  • [50] Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival
    Viehl, Carsten T.
    Weixler, Benjamin
    Guller, Ulrich
    Dell-Kuster, Salome
    Rosenthal, Rachel
    Ramser, Michaela
    Banz, Vanessa
    Langer, Igor
    Terracciano, Luigi
    Sauter, Guido
    Oertli, Daniel
    Zuber, Markus
    CANCER MEDICINE, 2017, 6 (05): : 918 - 927